Peer Review History
| Original SubmissionNovember 8, 2021 |
|---|
|
PONE-D-21-35561Repeatability of choriocapillaris flow voids by optical coherence tomography angiography in central serous chorioretinopathy.PLOS ONE Dear Dr. Fernández-Vigo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all points raised during the review process. I also sincerely apologise for the very long delay in the review process. A main limitation in the study is that full details of the methods used and the criteria for analyses are not fully presented or explained. These details are important to establish whether the method is repeatable and can be applied by other investigators. Please see below comments that should be addressed; there are both major and minor issues. Major Comment 1. Page 6, line 117 “All OCTA images were acquired by two well-trained examiners (FJMM and JIFV). Only images of sufficient quality, as determined by a signal quality >7/10, were accepted.” Please provide details on intra- and inter-observer image acquisition. Is the >7/10 signal quality used here, specific to the OCTA instrument used in this study, or a general feature? The criteria for a quality image are relevant in establishing a useful method. Thank you. 2. Page 8, line 148 “FSV was defined as the proportion of absence of blood flow relative to the total area measured.” Please clarify that FSV used in the analyses was not individual areas but rather a relative area that did not have blood flow per total macula area measured. 3. Page 8, line 158 “Different combinations of thresholds were tested and a threshold of 30 was selected as the most appropriate. Last, a filter of the detected 160 flow voids was performed on this binary image, keeping those with an area greater than 20 pixels (0,686 μm2) after the application of a soft dilation.” Line 163 “Different area sizes were tested when applying the size filter and the most appropriate one was selected.” For the above parameters, how was ‘appropriate’ defined? Why was 20pixels selected as the cut-ff for the FSV area? 4. A summary flow diagram indicating the series of processes used, the two algorithms applied and decisions to establish the final method should be included. These further details for defining the method used. 5. Page 15, Discussion. The comments on the effects of subretinal fluid in CSCR (and presumably other conditions) are very relevant and useful for clinical applications of OCTA. It would be useful to assess the same eyes with CSCR after resolution of the subretinal fluid (not just compare with unaffected other eyes of each patient). Although this is likely not practical, can the authors comment on any observations they have made post-resolution of SRF in their patients in relation to their technique and repeatability. Thank you. 6. The three levels of image slabs taken all start from the RPE and are measured vertically into the underlying choriocapillaris and choroid. May have missed this, but how many scans are included for each slab? The two choriocapillaris slabs are 15 micron and 20 microns respectively, measured from the RPE/Bruch’s membrane location. The authors do mention whether taking measurements from Satller’s layer may be helpful however, based on histology, defining the outer choroidal vessel layers is not always clearly defined. Minor comments 1. Please further clarify the exclusion criteria applied for selecting participants in the study, including details on types of pathology or disease. Were differences between right and left eyes, and gender analysed? 2. Line 150: “.. range of values using a mix max..” – should this be “min-max” here? 3. Line 153: What are the units for the 8x8 mentioned here? Please submit your revised manuscript by Dec 01 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Michele Madigan Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1, Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Manuscript Number PONE-D-21-35561 “Repeatability of choriocapillaris flow voids by optical coherence tomography angiography in central serous chorioretinopathy" This is a cross-sectional study which examined the intra-visit repeatability of the choroidal flow voids eyes with CSR. The study is an imaging methodological paper on choriocapillaris images in CSR eyes. Major comments 1. Please provide the inter-grader (2 persons extracting the same slab from the same scan) and intra-grader (1 person extracting the same slab from the same scan twice) reliability. 2. Please provide the definition or the standard of appropriate: “Different combinations of thresholds were tested and a threshold of 30 was selected as the most appropriate. Different area sizes were tested when applying the size filter and the most appropriate one was selected.” 3. Please provide a rationale for analysis of the three slabs at this specific layers/thickness/depth. 4. Please define FSV area – is this the size of single flow void or the total area of flow void in the scan. The authors have only showed the FSV area. Please also show the density of flow void. 5. Please compare the results between normal and CSR eyes. 6. Please also show the Bland–Altman plots of the different choriocapillaris flow void metrics. Minor comments 7. Please provide a step-by-step flow chart on how the image processing was carried out. 8. Were the two scans aligned before the analysis? Previous study (PMID: 31833241) used a customized software to align the scan prior to analysis. Was the eye tracker turned on during the scanning of the two consecutive macular scans? 9. Please elaborate the types of pathologies excluded from the study. “Exclusion criteria were ocular or systemic pathology…” 10. Were scans with other types of artifacts i.e., motion or poor segmentation excluded from the study? “Only images of sufficient quality, as determined by a signal quality >7/10, were accepted.” 11. Figure 2. Please clarify exploration 1 and 2. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Repeatability of choriocapillaris flow voids by optical coherence tomography angiography in central serous chorioretinopathy. PONE-D-21-35561R1 Dear Dr. Fernández-Vigo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michele Madigan Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All the comments have been well addressed. No further comments. Appreciate the authors' detailed revision. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-21-35561R1 Repeatability of choriocapillaris flow voids by optical coherence tomography angiography in central serous chorioretinopathy. Dear Dr. Fernández-Vigo: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michele Madigan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .